Anti-cancer characteristics of mevinolin against three different solid tumor cell lines was not solely p53-dependent

Ali Mokhtar Mahmoud1, Ahmed M Al-Abd, David A Lightfoot

  • 1Faculty of Agriculture Research Park (FARP) and Biochemistry Department, Faculty of Agriculture, Cairo University, Giza, Egypt.

Insights

Mevinolin (MVN), a cholesterol-lowering drug, shows potent anti-cancer effects comparable to doxorubicin (DOX) against solid tumors. Its cytotoxicity is multi-factorial, offering promise for novel cancer therapies.

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Background:

  • Mevinolin (MVN) is clinically used for hypercholesterolemia with good patient tolerance.
  • Epidemiological data suggest MVN's potential in cancer treatment.
  • Previous studies indicated MVN activates a mixed apoptotic/necrotic cell death pathway.

Purpose of the Study:

  • To evaluate the cytotoxic profile of Mevinolin (MVN).
  • To compare MVN's efficacy against breast, cervical, and liver cancer cell lines with doxorubicin (DOX).
  • To investigate the mechanisms of MVN-induced cytotoxicity.

Main Methods:

  • Cytotoxicity assays were performed on MCF-7 (breast), HeLa (cervical), and HepG(2) (liver) cancer cell lines.
  • Mevinolin (MVN) and doxorubicin (DOX) were used as treatment agents.
  • The role of p53 expression in MVN-induced cell death was assessed.

Main Results:

  • Mevinolin (MVN) demonstrated a cytotoxic profile comparable to doxorubicin (DOX) across all tested solid tumor cell lines.
  • MVN-induced cytotoxicity was found to be multi-factorial.
  • Cytotoxicity was not solely dependent on p53 expression.

Conclusions:

  • Mevinolin (MVN) exhibits significant anti-cancer potential against solid tumors.
  • The multi-factorial nature of MVN's cytotoxicity warrants further investigation.
  • Molecular and genetic assessment of MVN-induced cell death could inform future cancer therapeutic strategies.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...